Melbourne Gastrointestinal Investigation Unit (MGIU)

Malvern, Victoria 3144

0 studies enrolling now · 2 studies all time

What they study most

Ulcerative Colitis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed